4.7 Editorial Material

Molecular Imaging of Hypoxia

期刊

JOURNAL OF NUCLEAR MEDICINE
卷 52, 期 2, 页码 165-168

出版社

SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.110.075663

关键词

hypoxia; PET; optical imaging; nitroimidazole

资金

  1. NCI NIH HHS [R01 CA040355, P01 CA042745-23, R37 CA042324, R01 CA040355-28, P01 CA042745, R01 CA042324, CA40355, CA42324] Funding Source: Medline
  2. NCRR NIH HHS [P41 RR005959] Funding Source: Medline
  3. NINDS NIH HHS [P50 NS020023] Funding Source: Medline

向作者/读者索取更多资源

A wide variety of imaging approaches have been developed in the past few decades for monitoring tumor oxygenation and hypoxia in vivo. In particular, nuclear medicine has seen the development of several radiolabeled hypoxia markers and is the preferred method for imaging of tumor hypoxia. Hypoxia imaging is increasingly being used in the clinical setting and is progressing from a mere detection method to application in individualization of chemoradiotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据